Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

fam-trastuzumab deruxtecan

fam-trastuzumab deruxtecan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Enhertu POWDER FOR INJECTION, INJECTABLE 100 mg      
Comments:

Restricted to use in outpatient infusion setting. Insurance certification or PAP eligibility review required with each case before use. May be administered as "patient own medication" through PAP.

Reviewed: March 2021 (Enhertu)

Last updated: Feb. 3, 2025
Rhazdrugs fam-trastuzumab deruxtecan






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved